ABSTRACT
Up to October 31, 2012, a total of 170 food samples marketed in Saitama Prefecture were examined following the setting of provisional regulatory limits for radioactivity in drinking water and foodstuffs by the Ministry of Health, Labour and Welfare on 1 April 2012. No sample exceeded the regulatory limits as determined by gamma ray spectrometry with a germanium semiconductor detector. However the radioactive cesium concentrations of food samples such as raw wood-shiitake and maccha (powdered green tea) produced in Saitama were nearly at the regulatory limits, being 74 Bq/kg and 84 Bq/kg, respectively.
Subject(s)
Crops, Agricultural/chemistry , Food Analysis/methods , Food Contamination, Radioactive/analysis , Water/chemistry , Food Analysis/instrumentation , Fukushima Nuclear Accident , Germanium , Japan , Radioactive Hazard Release , Semiconductors , Spectrometry, Gamma/methodsABSTRACT
This study developed a simple and sensitive method using reversed-phase high-performance liquid chromatography (HPLC) for ganciclovir (GCV) plasma concentrations in cytomegalovirus infectious infants with hearing loss. The method involves a simple protein precipitation procedure that uses no solid-phase or liquid-liquid extraction. The HPLC separation was carried out on a Cadenza CD-C(18) column (3 microm, 4.6 mm x 150 mm) with phosphate buffer (pH 2.5, 25 mM) containing 1% methanol-acetonitrile mixture (4:3, v/v) as a mobile phase at a 0.7 mL/min flow rate. GCV was detected using a fluorescence detection (lambdaex/em: 265/380 nm). The quantification limit was 0.025 microg/mL for 100 microL of plasma sample at which good intra- and inter-assay coefficient of variation values (< 4.96%) and recoveries (94.9-96.5%) were established.
Subject(s)
Antiviral Agents/blood , Chromatography, High Pressure Liquid/methods , Chromatography, Reverse-Phase/methods , Ganciclovir/blood , Chromatography, High Pressure Liquid/economics , Chromatography, Reverse-Phase/economics , Fluorescence , Humans , Infant , Limit of Detection , Linear ModelsABSTRACT
This study developed a simple method for the simultaneous determination of zonisamide (ZNS), carbamazepine (CBZ) and its active metabolite, carbamazepine-10,11-epoxide (CBZE) in infant serum using reversed-phase high-performance liquid chromatograph (HPLC). The method involves a single-step protein precipitation procedure that uses no solid-phase or liquid-liquid extraction. The HPLC separation was carried out on a Cadenza CD-C18 column (3 microm, 4.6 mm x 150 mm) with potassium phosphate buffer (pH 4.6; 25 mM)-methanol-acetonitrile (65:20:15 (v/v/v)) as a mobile phase at a 1.0 ml/min flow rate: ZNS was detectable using a UV detector at 235 nm, and both CBZ and CBZE were at 215 nm. The quantification limits were established in accordance with each therapeutic range at 2.5 microg/ml for ZNS, 0.5 microg/ml for CBZ, and 0.25 microg/ml for CBZE. The respective coefficients of variation were 1.3-6.0% and 2.2-7.7% for the intra- and inter-assay.